Anabolic
IGF-1 LR3
20–100 mcg/day
Injection (IM or SubQ)
Starting from
R360
4 suppliers available
- see pricing tab below
Dosage
20–100 mcg/day
Administration
Injection (IM or SubQ)
Category
Anabolic
Overview
IGF-1 LR3 is a long-acting analogue of insulin-like growth factor 1 with an extended half-life (~20 hours). It is a potent anabolic peptide that drives muscle hypertrophy and fat loss.
Mechanism of Action
Binds to IGF-1 receptors in muscle tissue, promoting protein synthesis, satellite cell activation, and muscle hypertrophy. Inhibits apoptosis and stimulates glucose uptake.
Key Benefits
- Promotes significant muscle hypertrophy
- Increases satellite cell activation
- Reduces fat mass
- Synergistic with GH secretagogues
Side Effects & Safety
- Hypoglycaemia (especially without adequate carbohydrate intake), jaw pain, organ growth with long-term use at high doses.
Research & Stacking Notes
20–50 mcg IM or SubQ post-workout, 5 days on, 2 days off. Consume fast-acting carbohydrates immediately after injection.
Select your preferred supplier and add to cart. Prices shown include VAT.
| Supplier / Lab | Strength / Volume | Price | Availability | |
|---|---|---|---|---|
|
UP
UPA Labs
Australia
|
100mcg
1 Vial
|
R360
|
In Stock | |
|
VM
VMed
South Africa
|
100mcg
1 Vial
|
R790
|
In Stock | |
|
KE
Keifei Pharmaceuticals
Malaysia
|
100mcg
3 Vials
|
R1,150
|
In Stock | |
|
HD
HD Labs
South Africa
|
100mcg
10 vials
|
R2,400
|
In Stock |
All peptides are for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.
Always consult a qualified healthcare professional before use.